Form 8-K - Current report:
SEC Accession No. 0001628280-23-010813
Filing Date
2023-04-05
Accepted
2023-04-05 11:39:05
Documents
15
Period of Report
2023-04-05
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K csbr-20230405.htm   iXBRL 8-K 39434
2 EX-99.1 csbr452023ex991xsharerepur.htm EX-99.1 9812
7 GRAPHIC logobranding_headerleftali.jpg GRAPHIC 32167
  Complete submission text file 0001628280-23-010813.txt   227360

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT csbr-20230405.xsd EX-101.SCH 2184
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT csbr-20230405_def.xml EX-101.DEF 2919
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT csbr-20230405_lab.xml EX-101.LAB 24124
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT csbr-20230405_pre.xml EX-101.PRE 13164
9 EXTRACTED XBRL INSTANCE DOCUMENT csbr-20230405_htm.xml XML 3808
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-11504 | Film No.: 23801668
SIC: 2836 Biological Products, (No Diagnostic Substances)